Atrium Health Wake Forest Baptist Treats First Patient With FDA-Approved Alzheimer's Disease Drug
March 15, 2024
March 15, 2024
WINSTON-SALEM, North Carolina, March 15 -- Atrium Health Wake Forest Baptist issued the following news release on March 14, 2024:
Today, Atrium Health Wake Forest Baptist became the first health system in the region to treat a patient with lecanemab, a new medication for Alzheimer's disease. This is the first Alzheimer's drug approved by the FDA in more than 20 years.
Alzheimer's disease is a type of dementia that affects memory, thinking and behavior. It is a progressi . . .
Today, Atrium Health Wake Forest Baptist became the first health system in the region to treat a patient with lecanemab, a new medication for Alzheimer's disease. This is the first Alzheimer's drug approved by the FDA in more than 20 years.
Alzheimer's disease is a type of dementia that affects memory, thinking and behavior. It is a progressi . . .